BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2010
View Archived Issues
Alkermes to initiate clinical development of ALKS-9070 for schizophrenia in 2010
Read More
Flutiform NDA transferred from Abbott Laboratories to SkyePharma
Read More
EntreMed raises funds to further develop ENMD-2076
Read More
Bioheart begins phase I trial of genetically modified MyoCell in CHF
Read More
Merck & Co. describes discovery of novel orally bioavailable cathepsin K inhibitor MK-0674
Read More
Lux Biosciences files for approvals in the U.S. and Europe for voclosporin in uveitis
Read More
Pregabalin shows potential as a treatment for alcohol withdrawal syndrome
Read More
Novartis describes efforts to target PDK1 in oncology
Read More
Modest cellular immune responses seen with ADVAX HIV-1 candidate vaccine
Read More
XenoPort chooses Horizant as brand name for gabapentin enacarbil in the U.S.
Read More
Correlation between dopaminergic activity and pain sensitivity in healthy subjects identified
Read More
BioMarin signs stock purchase agreement to acquire LEAD Therapeutics and LT-673
Read More
OsteoGeneX claims Wnt pathway modulators for the treatment of bone diseases
Read More
Natural products with oncolytic activity identified by South African scientists
Read More
Johns Hopkins University and FASgen claim novel oncolytic agents
Read More
Novel tachykinin NK2 antagonists described by Roche
Read More
BioTime reports results of Hextend trial in unstable trauma patients
Read More
ArQule initiates phase II trial of ARQ-197 in GCT and phase I/II trial in CRC
Read More
7TM Pharma identifies novel CB1 receptor antagonists
Read More
Novel compounds for cancer therapy discovered by Japanese scientists
Read More
BioMarin reports preliminary results from phase I/II trial of BMN-110 in MPS IVA
Read More
Optimer reports topline results from phase III trial of fidaxomicin in CDI
Read More
Genmab outlicenses zanolimumab to TenX Biopharma
Read More
Mitsubishi Tanabe reports results from third quarter of 2009 ended December 31
Read More
Daiichi Sankyo submits SUN-Y7017 NDA in Japan for Alzheimer's type dementia
Read More
European Commission grants marketing authorization for silodosin in BPH
Read More